Surgepays Stock Analysis
SURG Stock | USD 1.98 0.03 1.54% |
Surgepays is undervalued with Real Value of 4.63 and Target Price of 13.0. The main objective of Surgepays stock analysis is to determine its intrinsic value, which is an estimate of what Surgepays is worth, separate from its market price. There are two main types of Surgepays' stock analysis: fundamental analysis and technical analysis.
The Surgepays stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Surgepays' ongoing operational relationships across important fundamental and technical indicators.
Surgepays |
Surgepays Stock Analysis Notes
About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.13. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgepays has Price/Earnings To Growth (PEG) ratio of 0.53. The entity recorded a loss per share of 1.18. The firm had not issued any dividends in recent years. Surgepays had 1:50 split on the 2nd of November 2021. SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. Surgepays operates under SoftwareApplication classification in the United States and is traded on NASDAQ Exchange. It employs 32 people. To find out more about Surgepays contact Kevin Cox at 901 302 9587 or learn more at https://surgepays.com.Surgepays Quarterly Total Revenue |
|
Surgepays Investment Alerts
Surgepays is way too risky over 90 days horizon | |
Surgepays may become a speculative penny stock | |
Surgepays appears to be risky and price may revert if volatility continues | |
About 32.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from simplywall.st: Investors Appear Satisfied With SurgePays, Inc.s Prospects As Shares Rocket 25 |
Surgepays Upcoming and Recent Events
4th of April 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Surgepays Largest EPS Surprises
Earnings surprises can significantly impact Surgepays' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2015-06-30 | 2015-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2014-12-31 | 2014-12-31 | 0.02 | 0.03 | 0.01 | 50 | ||
2014-09-30 | 2014-09-30 | 0.02 | 0.03 | 0.01 | 50 |
Surgepays Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Corsair Capital Management Llc | 2024-09-30 | 29.9 K | Cetera Investment Advisers | 2024-09-30 | 22.2 K | Two Sigma Securities, Llc | 2024-09-30 | 19.3 K | Royce & Associates, Lp | 2024-09-30 | 18.6 K | Advisor Group Holdings, Inc. | 2024-06-30 | 16.6 K | James Investment Research, Inc. | 2024-09-30 | 13 K | Goss Wealth Management Llc | 2024-09-30 | 13 K | Susquehanna International Group, Llp | 2024-09-30 | 12.1 K | Simplex Trading, Llc | 2024-09-30 | 8 K | Vanguard Group Inc | 2024-09-30 | 587 K | Cable Car Capital Llc | 2024-09-30 | 515 K |
Surgepays Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 37.5 M.Surgepays Profitablity
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.72) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.72.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.55 | 0.58 | |
Return On Capital Employed | 0.65 | 0.68 | |
Return On Assets | 0.49 | 0.52 | |
Return On Equity | 0.73 | 0.69 |
Management Efficiency
Surgepays has return on total asset (ROA) of (0.0151) % which means that it has lost $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0519) %, meaning that it created substantial loss on money invested by shareholders. Surgepays' management efficiency ratios could be used to measure how well Surgepays manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgepays' Return On Assets are most likely to increase significantly in the upcoming years. At this time, Surgepays' Non Current Assets Total are most likely to increase significantly in the upcoming years. The Surgepays' current Non Currrent Assets Other is estimated to increase to about 213.5 K, while Intangible Assets are projected to decrease to roughly 2 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.99 | 3.96 | |
Tangible Book Value Per Share | 1.69 | 3.06 | |
Enterprise Value Over EBITDA | 4.12 | 4.33 | |
Price Book Value Ratio | 3.26 | 3.42 | |
Enterprise Value Multiple | 4.12 | 4.33 | |
Price Fair Value | 3.26 | 3.42 | |
Enterprise Value | 82.8 M | 86.9 M |
The strategic initiatives led by Surgepays' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Operating Margin (0.72) | Profit Margin (0.01) | Beta 1.392 | Return On Assets (0.02) | Return On Equity (0.05) |
Technical Drivers
As of the 3rd of December, Surgepays has the Coefficient Of Variation of 1405.38, risk adjusted performance of 0.0631, and Semi Deviation of 5.11. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgepays, as well as the relationship between them. Please validate Surgepays information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Surgepays is priced more or less accurately, providing market reflects its prevalent price of 1.98 per share. Please also confirm Surgepays total risk alpha, which is currently at (0.49) to double-check the company can sustain itself at a future point.Surgepays Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Surgepays middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Surgepays. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Surgepays Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgepays insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgepays' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgepays insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Surgepays Outstanding Bonds
Surgepays issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Surgepays uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Surgepays bonds can be classified according to their maturity, which is the date when Surgepays has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Surgepays Predictive Daily Indicators
Surgepays intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgepays stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Surgepays Forecast Models
Surgepays' time-series forecasting models are one of many Surgepays' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgepays' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Surgepays Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgepays prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgepays shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Surgepays. By using and applying Surgepays Stock analysis, traders can create a robust methodology for identifying Surgepays entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.13 | 0.14 | |
Operating Profit Margin | 0.14 | 0.14 | |
Net Profit Margin | 0.15 | 0.16 | |
Gross Profit Margin | 0.26 | 0.27 |
Current Surgepays Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgepays analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Surgepays analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
13.0 | Buy | 2 | Odds |
Most Surgepays analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Surgepays stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Surgepays, talking to its executives and customers, or listening to Surgepays conference calls.
Surgepays Stock Analysis Indicators
Surgepays stock analysis indicators help investors evaluate how Surgepays stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Surgepays shares will generate the highest return on investment. By understating and applying Surgepays stock analysis, traders can identify Surgepays position entry and exit signals to maximize returns.
Begin Period Cash Flow | 7 M | |
Total Stockholder Equity | 28.2 M | |
Capital Lease Obligations | 399.4 K | |
Property Plant And Equipment Net | 749.7 K | |
Cash And Short Term Investments | 14.6 M | |
Cash | 14.6 M | |
50 Day M A | 1.7359 | |
Net Interest Income | -596 K | |
Total Current Liabilities | 12.7 M | |
Forward Price Earnings | 8 | |
Investments | -281.3 K | |
Interest Expense | 596 K | |
Stock Based Compensation | 529.5 K | |
Long Term Debt | 460.5 K | |
Common Stock Shares Outstanding | 14.9 M | |
Tax Provision | -2.3 M | |
Quarterly Earnings Growth Y O Y | -0.777 | |
Free Cash Flow | 10 M | |
Other Current Assets | 161.9 K | |
Accounts Payable | 6.4 M | |
Net Debt | -9.2 M | |
Other Operating Expenses | 118.3 M | |
Non Current Assets Total | 8.6 M | |
Liabilities And Stockholders Equity | 41.9 M | |
Non Currrent Assets Other | 176.9 K |
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stocks Directory Find actively traded stocks across global markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |